annb0t
Top 20
Opthea Limited
Podium presentation on the pharmacokinetics and safety of OPT-302 in retinal vascular diseases Participation in âLive From ASRSâ virtual KOL discussion on market trends and new treatments in wet AMD hosted by Oppenheimer & Co.
MELBOURNE, Australia, July 13, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that O...
>>> Read more: Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting
Podium presentation on the pharmacokinetics and safety of OPT-302 in retinal vascular diseases Participation in âLive From ASRSâ virtual KOL discussion on market trends and new treatments in wet AMD hosted by Oppenheimer & Co.
MELBOURNE, Australia, July 13, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that O...
>>> Read more: Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting
